TCS, HDFCBANK, SBI Liquid Fund (G)
Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Phar
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 18 05 2021 | Dividend & Audited Results |
| 26 07 2021 | Quarterly Results |
| 29 10 2021 | Quarterly Results |
| 07 02 2022 | Quarterly Results |
| 16 05 2022 | Audited Results & Dividend |
| 25 07 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 07 02 2023 | Quarterly Results |
| 17 05 2023 | Final Dividend & Audited Results |
| 26 07 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 29 10 2024 | Interim Dividend & Quarterly Results |
| 10 02 2025 | Quarterly Results(Cancelled) (Cancelled) |
| 10 02 2025 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 13 05 2025 | Final Dividend & Audited Results |
News
No News data available
